Central New York Research Corp is categorized under Medical Research in Syracuse, NY and active since 1989.
Central New York Research Corp was established in 1989, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6221100 by the NAICS.
If you are seeking more information, feel free to contact James Cody, Manager at the company’s single location by writing to 800 Irving Avenue, Syracuse, New York NY 13210 or by phoning (315) 472-6123. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central New York Research Corp |
| Contact Person: | James Cody, Manager |
| Address: | 800 Irving Avenue, Syracuse, New York 13210 |
| Phone Number: | (315) 472-6123 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1989 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 6221100 |
| Share This Business: |
Central New York Research Corp was started in 1989 to provide professional Medical Research under the SIC code 8733 and NAICS code 6221100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact James Cody, Manager for inquiries that concern Central New York Research Corp by calling the company number (315) 472-6123, as your correspondence is most welcome. Additionally, the physical location of the single location of Central New York Research Corp can be found at the coordinates 43.038567,-76.138254 as well as the street address 800 Irving Avenue in Syracuse, New York 13210.
For its online presence, you may visit Central New York Research Corp’s website at and engage with its social media outlets through on Twitter and on Facebook.